Uncategorized

Current neuroendocrine research consistently highlights the Melanocortin-4 receptor (MC4R) as a key regulator of appetite and overall energy balance. In laboratory models, Melanotan II is commonly used as a non-selective agonist of melanocortin receptors to study MC4R-related signaling pathways, owing to its strong receptor affinity. Additionally,  foundational neurobiology literature [1] shows that activating MC4R in hypothalamic regions

Orforglipron functions as a selective agonist of the glucagon-like peptide-1 (GLP-1) receptor, a class B G protein–coupled receptor involved in appetite regulation, nutrient sensing, and metabolic coordination. GLP-1 pathway studies published by Molecular Mechanisms [1] demonstrate that receptor activation influences hypothalamic satiety circuits, gastric emptying, insulin secretion, and peripheral energy signaling. Therefore, receptor engagement allows investigators to